Seegene introduces a High-throughput 8-plex Test for Flu A, Flu B, RSV and COVID-19 with dual internal controls
SEOUL, South Korea, Sept. 8, 2020 /PRNewswire/ — Seegene, Inc. introduced a single tube real-time RT-PCR assay, Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay, which simultaneously detects and differentiates Flu A,
Seegene’s Allplex™ 2019-nCoV Assay receives FDA Emergency Use Authorization
Published on: 매일경제 한국경제 PR Newswire 조선일보 SEOUL, Korea, Apr 22, 2020 – Seegene, Inc. announced that U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA)
Seegene exported 10 Million COVID-19 Diagnostic Tests to Over 60 countries
Published on: PR Newswire ABC News Seegene, Inc., the leading multiplex diagnostic assay developer, today announced that the company has exported over 10 million tests of
Seegene Highlights Clinical Automated Nucleic Acid Extraction System at ASM Microbe 2019
2019 American Society for Microbiology Microbe Conference: Booth #1062 Published on: PR Newswire SEOUL, South Korea, June 21, 2019 /PRNewswire/ — Seegene Inc. (096530.KQ), a leading developer
Seegene launches a new anti-microbial drug resistance test kit, replacing the conventional culture method
Published on: PR Newswire SEOUL, South Korea, Nov. 26, 2018 /PRNewswire/ — Seegene Inc. (096530.KQ), a leading developer of multiplex PCR assays, announced that multi-site clinical trials for measuring
Seegene Unveils New Real-time PCR Analysis Technology, Drastically Increasing Its Multiplexing Capacity
Published on: PR Newswire SEOUL, South Korea, Sept. 19, 2018 /PRNewswire/ — Seegene Inc. (096530.KQ), a leading developer of multiplex PCR technologies, today announced its proprietary technology,